id	sid	eid	entity	type
bptjm-40	1	1	berkeley pharma tech journal	ORG
bptjm-40	2	1	1	CARDINAL
bptjm-40	2	2	65	CARDINAL
bptjm-40	2	3	1	CARDINAL
bptjm-40	2	4	ptchd1	WORK_OF_ART
bptjm-40	2	5	january 20	DATE
bptjm-40	2	6	2023	CARDINAL
bptjm-40	2	7	february 9	DATE
bptjm-40	2	8	2023	CARDINAL
bptjm-40	2	9	june 30	DATE
bptjm-40	2	10	2023	CARDINAL
bptjm-40	2	11	4.0	CARDINAL
bptjm-40	4	1	up to 80%	PERCENT
bptjm-40	7	1	ashley varatip	PERSON
bptjm-40	7	2	serena z. h. huang	PERSON
bptjm-40	7	3	yash kilam	PERSON
bptjm-40	7	4	cameron asadi	PERSON
bptjm-40	7	5	1.1	CARDINAL
bptjm-40	8	1	2016	DATE
bptjm-40	8	2	6.1 million	CARDINAL
bptjm-40	8	3	9.4%	PERCENT
bptjm-40	8	4	2-17	DATE
bptjm-40	8	5	the united states	GPE
bptjm-40	8	6	1	CARDINAL
bptjm-40	9	1	1	CARDINAL
bptjm-40	9	2	20	CARDINAL
bptjm-40	9	3	the united states	GPE
bptjm-40	9	4	1	CARDINAL
bptjm-40	11	1	2.5-4.4%	PERCENT
bptjm-40	11	2	the united states	GPE
bptjm-40	11	3	around 2.8%	PERCENT
bptjm-40	11	4	2	CARDINAL
bptjm-40	14	1	3	CARDINAL
bptjm-40	17	1	1.2	CARDINAL
bptjm-40	17	2	this day	DATE
bptjm-40	18	1	4	CARDINAL
bptjm-40	19	1	5	CARDINAL
bptjm-40	20	1	80%	PERCENT
bptjm-40	20	2	6	CARDINAL
bptjm-40	21	1	4	CARDINAL
bptjm-40	21	2	1.3	CARDINAL
bptjm-40	22	1	7	CARDINAL
bptjm-40	24	1	berkeley pharma tech journal	ORG
bptjm-40	25	1	60	CARDINAL
bptjm-40	27	1	six months	DATE
bptjm-40	27	2	the age of twelve 7	DATE
bptjm-40	29	1	7	CARDINAL
bptjm-40	30	1	8	CARDINAL
bptjm-40	31	1	1.4	CARDINAL
bptjm-40	32	1	9	CARDINAL
bptjm-40	33	1	10	CARDINAL
bptjm-40	34	1	three	CARDINAL
bptjm-40	37	1	10	CARDINAL
bptjm-40	38	1	fda	ORG
bptjm-40	38	2	29	CARDINAL
bptjm-40	38	3	ritalin	ORG
bptjm-40	38	4	twenty-nine	CARDINAL
bptjm-40	38	5	9	CARDINAL
bptjm-40	39	1	70-80%	PERCENT
bptjm-40	39	2	9	CARDINAL
bptjm-40	41	1	9	CARDINAL
bptjm-40	43	1	9	CARDINAL
bptjm-40	44	1	berkeley pharma tech journal	ORG
bptjm-40	44	2	61	CARDINAL
bptjm-40	44	3	9	CARDINAL
bptjm-40	46	1	9	CARDINAL
bptjm-40	47	1	9	CARDINAL
bptjm-40	48	1	20-30%	PERCENT
bptjm-40	48	2	9	CARDINAL
bptjm-40	50	1	11	CARDINAL
bptjm-40	52	1	11	CARDINAL
bptjm-40	55	1	12	CARDINAL
bptjm-40	56	1	250	CARDINAL
bptjm-40	56	2	two	CARDINAL
bptjm-40	61	1	12	CARDINAL
bptjm-40	62	1	berkeley pharma tech journal	ORG
bptjm-40	62	2	62	CARDINAL
bptjm-40	64	1	13	CARDINAL
bptjm-40	66	1	1	CARDINAL
bptjm-40	66	2	65	CARDINAL
bptjm-40	66	3	1	CARDINAL
bptjm-40	66	4	1	CARDINAL
bptjm-40	67	1	5.1	CARDINAL
bptjm-40	67	2	1	CARDINAL
bptjm-40	67	3	1	CARDINAL
bptjm-40	68	1	neurexins	PERSON
bptjm-40	68	2	nrxn1	GPE
bptjm-40	68	3	nrxn2	GPE
bptjm-40	68	4	nrxn3	ORG
bptjm-40	68	5	14	CARDINAL
bptjm-40	70	1	berkeley pharma tech journal	ORG
bptjm-40	70	2	63	CARDINAL
bptjm-40	70	3	15	CARDINAL
bptjm-40	71	1	nrxn1 14	ORG
bptjm-40	72	1	nrxn1	GPE
bptjm-40	73	1	nrxn1	GPE
bptjm-40	73	2	15	CARDINAL
bptjm-40	74	1	nrxn1	GPE
bptjm-40	75	1	one	CARDINAL
bptjm-40	75	2	15	CARDINAL
bptjm-40	76	1	four-week-old	DATE
bptjm-40	76	2	two	CARDINAL
bptjm-40	79	1	15	CARDINAL
bptjm-40	82	1	nrxn1	GPE
bptjm-40	82	2	nlgn1	ORG
bptjm-40	83	1	15	CARDINAL
bptjm-40	84	1	5.2	CARDINAL
bptjm-40	84	2	2	CARDINAL
bptjm-40	84	3	3	CARDINAL
bptjm-40	84	4	d4	ORG
bptjm-40	84	5	16	CARDINAL
bptjm-40	86	1	17	CARDINAL
bptjm-40	87	1	17	CARDINAL
bptjm-40	88	1	berkeley pharma tech journal	ORG
bptjm-40	88	2	64	CARDINAL
bptjm-40	90	1	13	CARDINAL
bptjm-40	91	1	18	CARDINAL
bptjm-40	92	1	two	CARDINAL
bptjm-40	92	2	13	CARDINAL
bptjm-40	95	1	575	CARDINAL
bptjm-40	95	2	6 to 12	DATE
bptjm-40	95	3	three	CARDINAL
bptjm-40	96	1	one week	DATE
bptjm-40	96	2	one week	DATE
bptjm-40	96	3	one week	DATE
bptjm-40	96	4	18	CARDINAL
bptjm-40	98	1	the mph week	DATE
bptjm-40	100	1	18	CARDINAL
bptjm-40	100	2	5.3	CARDINAL
bptjm-40	100	3	3	CARDINAL
bptjm-40	100	4	65	CARDINAL
bptjm-40	100	5	65	CARDINAL
bptjm-40	101	1	19	CARDINAL
bptjm-40	102	1	20	CARDINAL
bptjm-40	103	1	20	CARDINAL
bptjm-40	104	1	14	CARDINAL
bptjm-40	104	2	20	CARDINAL
bptjm-40	104	3	15	CARDINAL
bptjm-40	105	1	berkeley pharma tech journal	ORG
bptjm-40	105	2	65	CARDINAL
bptjm-40	105	3	igg	ORG
bptjm-40	105	4	20	CARDINAL
bptjm-40	106	1	15%	PERCENT
bptjm-40	106	2	27%	PERCENT
bptjm-40	107	1	60%	PERCENT
bptjm-40	107	2	53%	PERCENT
bptjm-40	107	3	purkinje	ORG
bptjm-40	107	4	mouse cerebellum and	FAC
bptjm-40	107	5	20%	PERCENT
bptjm-40	107	6	20	CARDINAL
bptjm-40	109	1	5.4	CARDINAL
bptjm-40	109	2	4	CARDINAL
bptjm-40	109	3	1	CARDINAL
bptjm-40	109	4	1	CARDINAL
bptjm-40	109	5	ptchd1	WORK_OF_ART
bptjm-40	111	1	21	CARDINAL
bptjm-40	112	1	one	CARDINAL
bptjm-40	112	2	1-ethyl	QUANTITY
bptjm-40	112	3	21	CARDINAL
bptjm-40	116	1	ptchd1 ko	PERSON
bptjm-40	116	2	kp	ORG
bptjm-40	118	1	kp	ORG
bptjm-40	119	1	ptchd1	PERSON
bptjm-40	119	2	kp	ORG
bptjm-40	119	3	berkeley pharma tech journal	ORG
bptjm-40	119	4	66	CARDINAL
bptjm-40	121	1	kp	ORG
bptjm-40	122	1	kp	ORG
bptjm-40	122	2	ptchd1	PERSON
bptjm-40	122	3	21	CARDINAL
bptjm-40	122	4	5.5	CARDINAL
bptjm-40	122	5	5	CARDINAL
bptjm-40	122	6	atx	ORG
bptjm-40	123	1	9	CARDINAL
bptjm-40	128	1	only one	CARDINAL
bptjm-40	128	2	22	CARDINAL
bptjm-40	133	1	berkeley pharma tech journal	ORG
bptjm-40	133	2	67	CARDINAL
bptjm-40	138	1	the past several years	DATE
bptjm-40	143	1	1	CARDINAL
bptjm-40	144	1	65	CARDINAL
bptjm-40	144	2	1	CARDINAL
bptjm-40	144	3	ptchd1	WORK_OF_ART
bptjm-40	148	1	berkeley pharma tech journal	ORG
bptjm-40	148	2	68	CARDINAL
bptjm-40	148	3	1	CARDINAL
bptjm-40	149	1	cdc	ORG
bptjm-40	149	2	2016	DATE
bptjm-40	151	1	september 9, 2020	DATE
bptjm-40	152	1	january 15	DATE
bptjm-40	152	2	2023	CARDINAL
bptjm-40	154	1	20findings-,national%20prevalence%20of%20adhd %	PERCENT
bptjm-40	154	2	20and%20treatment	MONEY
bptjm-40	154	3	20that%2c%20as	DATE
bptjm-40	154	4	2	CARDINAL
bptjm-40	156	1	october 6, 2006	DATE
bptjm-40	157	1	january 15	DATE
bptjm-40	157	2	2023	CARDINAL
bptjm-40	158	1	to%203.2%20pe rcent%20in%20women 3	LAW
bptjm-40	158	2	hagan	ORG
bptjm-40	158	3	s. the di	PERSON
bptjm-40	159	1	december 10	DATE
bptjm-40	159	2	2023	CARDINAL
bptjm-40	160	1	ndmkaj /https://www.sadag.org	ORG
bptjm-40	160	2	4	CARDINAL
bptjm-40	161	1	cdc	ORG
bptjm-40	164	1	january 26, 2021	DATE
bptjm-40	165	1	january 15	DATE
bptjm-40	165	2	2023	CARDINAL
bptjm-40	167	1	5	CARDINAL
bptjm-40	167	2	nhs	ORG
bptjm-40	169	1	2023	CARDINAL
bptjm-40	170	1	january 15	DATE
bptjm-40	170	2	2023	CARDINAL
bptjm-40	171	1	https://www.nhs.uk/conditions/attention-de�cit-hypera ctivity-disorder	PERSON
bptjm-40	171	2	6	CARDINAL
bptjm-40	172	1	grimm o	PERSON
bptjm-40	172	2	kranz	PERSON
bptjm-40	172	3	reif a. genetics	PERSON
bptjm-40	174	1	2020;22(4	CARDINAL
bptjm-40	175	1	7	CARDINAL
bptjm-40	175	2	nhs	ORG
bptjm-40	177	1	2023	CARDINAL
bptjm-40	178	1	january 15	DATE
bptjm-40	178	2	2023	CARDINAL
bptjm-40	179	1	https://www.nhs.uk/conditions/attention-de�cit-hypera ctivity-disorder	PERSON
bptjm-40	180	1	raspolich j. add	PERSON
bptjm-40	181	1	vista pines health	ORG
bptjm-40	182	1	september 12, 2021	DATE
bptjm-40	183	1	january 15	DATE
bptjm-40	183	2	2023	CARDINAL
bptjm-40	184	1	9	CARDINAL
bptjm-40	186	1	september 14, 2018	DATE
bptjm-40	187	1	january 15	DATE
bptjm-40	187	2	2023	CARDINAL
bptjm-40	188	1	0adhd%20medications-,adhd%20medications%20	CARDINAL
bptjm-40	188	2	strattera%20and%20intuniv%2c%20amon	ORG
bptjm-40	188	3	10	CARDINAL
bptjm-40	191	1	rxlist	PERSON
bptjm-40	192	1	march 31	DATE
bptjm-40	192	2	2021	DATE
bptjm-40	193	1	january 15	DATE
bptjm-40	193	2	2023	CARDINAL
bptjm-40	195	1	11	CARDINAL
bptjm-40	198	1	january 27, 2017	DATE
bptjm-40	199	1	january 15	DATE
bptjm-40	199	2	2023	CARDINAL
bptjm-40	200	1	12	CARDINAL
bptjm-40	201	1	anastopoulos	PERSON
bptjm-40	201	2	langberg jm	PERSON
bptjm-40	201	3	eddy ld	PERSON
bptjm-40	201	4	silvia pj	PERSON
bptjm-40	201	5	labban jd	PERSON
bptjm-40	204	1	2021;89(1):21-33	DATE
bptjm-40	205	1	berkeley pharma tech journal	ORG
bptjm-40	205	2	69 13	DATE
bptjm-40	206	1	fageera w	PERSON
bptjm-40	206	2	sengupta sm	PERSON
bptjm-40	206	3	r. drd3	PERSON
bptjm-40	209	1	14	CARDINAL
bptjm-40	210	1	m. neurexins	PERSON
bptjm-40	212	1	2013;14(9):213	CARDINAL
bptjm-40	213	1	14-9-213 15	TIME
bptjm-40	214	1	zhang s	PERSON
bptjm-40	214	2	wu	PERSON
bptjm-40	214	3	xu	PERSON
bptjm-40	218	1	doi:10.1016	PERSON
bptjm-40	218	2	16	CARDINAL
bptjm-40	219	1	database g. drd3 gene	PERSON
bptjm-40	221	1	2023	CARDINAL
bptjm-40	222	1	january 15	DATE
bptjm-40	222	2	2023	CARDINAL
bptjm-40	223	1	17	CARDINAL
bptjm-40	224	1	bhatia	PERSON
bptjm-40	227	1	july 18	DATE
bptjm-40	227	2	2022	CARDINAL
bptjm-40	228	1	january 15	DATE
bptjm-40	228	2	2023	CARDINAL
bptjm-40	229	1	18	CARDINAL
bptjm-40	229	2	chukwueke cc	PERSON
bptjm-40	229	3	kowalczyk wj	PERSON
bptjm-40	229	4	di ciano p	ORG
bptjm-40	231	1	2020;10(1	ORG
bptjm-40	232	1	doi:10.1038	ORG
bptjm-40	233	1	2021	CARDINAL
bptjm-40	234	1	january 15	DATE
bptjm-40	234	2	2023	CARDINAL
bptjm-40	235	1	cid%20decarboxylase%20 20.	ORG
bptjm-40	236	1	uk	GPE
bptjm-40	236	2	mungan nk	PERSON
bptjm-40	237	1	european child & adolescent psychiatry	ORG
bptjm-40	238	1	2012;21(3):141	CARDINAL
bptjm-40	241	1	wells mf	ORG
bptjm-40	241	2	wimmer rd	PERSON
bptjm-40	241	3	schmitt li	PERSON
bptjm-40	241	4	feng g	PERSON
bptjm-40	241	5	halassa mm	PERSON
bptjm-40	242	1	ptchd1y/−	PERSON
bptjm-40	244	1	2016;532(7597):58-63	CARDINAL
bptjm-40	245	1	doi:10.1038/nature17427 22	ORG
bptjm-40	246	1	raymond cm	PERSON
bptjm-40	248	1	environmental science &	ORG
bptjm-40	249	1	2017;77:15-24	DATE
bptjm-40	249	2	doi:10.1016/j.envsci.2017.07.008	ORG
bptjm-40	249	3	berkeley pharma tech journal	ORG
bptjm-40	249	4	70	CARDINAL